Reply to ‘Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumour response and tolerance’ by Funck-Brentano et al
| Autor: | L. Goldwirt, Samia Mourah, H. Sauvageon, Céleste Lebbé, I. Chami, C. Pages, Barouyr Baroudjian, Jean-Paul Feugeas, F. Brunet-Possenti, Clara Allayous, I. Madelaine |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Male
Proto-Oncogene Proteins B-raf Indoles Skin Neoplasms Tumour response 030226 pharmacology & pharmacy 03 medical and health sciences 0302 clinical medicine medicine Humans Vemurafenib Melanoma Sulfonamides business.industry Hematology medicine.disease Oncology 030220 oncology & carcinogenesis Mutation Mutation (genetic algorithm) Immunology Cancer research Female business medicine.drug |
| Zdroj: | Annals of Oncology. 27:363-364 |
| ISSN: | 0923-7534 |
| DOI: | 10.1093/annonc/mdv538 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|